NCT03702647View on ClinicalTrials.gov

Ropivacaine For Post-POEM Pain Control

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

January 18, 2021

Conditions
AchalasiaEsophageal Achalasia
Interventions
DRUG

Ropivacaine

30mL of 0.2% Ropivacaine placed in the POEM tunnel

DRUG

Normal saline

30mL of normal saline placed in the POEM tunnel

Trial Locations (1)

K7L 5G2

Kingston Health Sciences Centre, Kingston

All Listed Sponsors
lead

Lawrence Charles Hookey

OTHER

NCT03702647 - Ropivacaine For Post-POEM Pain Control | Biotech Hunter | Biotech Hunter